Published in Infect Control Hosp Epidemiol on February 01, 1998
Nosocomial infection update. Emerg Infect Dis (1998) 1.78
Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA (1999) 5.26
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA (1996) 4.80
Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06
The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med (1998) 2.94
Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs. Proc Natl Acad Sci U S A (1999) 2.75
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 2.53
Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis (1996) 2.49
Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J Infect Dis (1980) 2.48
Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis (2005) 2.47
Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis (2001) 2.46
Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet (1996) 2.44
A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med (1996) 2.38
Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline. Chest (2000) 2.36
Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences. Antimicrob Agents Chemother (1993) 2.03
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis (1996) 2.03
Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control. J Infect Dis (1976) 1.92
Structural and phenotypic varieties of gentamicin resistance plasmids in hospital strains of Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother (1982) 1.89
Pseudoepidemics in hospital. Lancet (1977) 1.89
Breast abscess: coagulase-negative staphylococcus as a sole pathogen. Clin Infect Dis (1993) 1.72
External sources of vancomycin-resistant enterococci for intensive care units. Crit Care Med (1998) 1.59
Hospital outbreaks caused by Pseudomonas aeruginosa: importance of serogroup O11. J Clin Microbiol (1982) 1.58
Association of infection caused by Pseudomonas aeruginosa serotype O11 with intravenous abuse of pentazocine mixed with tripelennamine. J Clin Microbiol (1984) 1.54
Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmids. J Infect Dis (1982) 1.54
AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen Intern Med (1996) 1.54
Stability of vancomycin-resistant enterococcal genotypes isolated from long-term-colonized patients. J Infect Dis (1998) 1.53
Variations in intensive care unit utilization for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia: importance of hospital characteristics and geographic location. Crit Care Med (1998) 1.52
Patients' endogenous flora as the source of "nosocomial" Enterobacter in cardiac surgery. J Infect Dis (1987) 1.49
Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1995) 1.48
Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed. J Infect Dis (1984) 1.46
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44
Early detection of false-positive acid-fast smears. An epidemiological approach. Lancet (1975) 1.39
Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am (1997) 1.37
Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis (2001) 1.36
Variations in institutional review board decisions for HIV quality of care studies: a potential source of study bias. J Acquir Immune Defic Syndr (2001) 1.36
Pressure monitoring devices. Overlooked source of nosocomial infection. JAMA (1976) 1.31
Comparison of endemic and epidemic nosocomial infections. Am J Med (1981) 1.31
Improvements in outcomes of acute respiratory failure for patients with human immunodeficiency virus-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (2000) 1.30
Multiresistant bacteria as a hospital epidemic problem. Ann Med (1998) 1.27
Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy. Infect Control (1986) 1.26
Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother (1983) 1.24
An outbreak of pneumocystis pneumonia in children with acute lymphocytic leukemia. Am J Dis Child (1978) 1.22
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis (1980) 1.20
Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control. J Infect Dis (1985) 1.19
The epidemiology of Pseudomonas aeruginosa in oncology patients in a general hospital. J Infect Dis (1989) 1.17
Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med (1998) 1.17
Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia. Clin Infect Dis (1997) 1.11
Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med (1985) 1.10
The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis (1999) 1.10
Racial differences in care among hospitalized patients with Pneumocystis carinii pneumonia in Chicago, New York, Los Angeles, Miami, and Raleigh-Durham. Arch Intern Med (1995) 1.09
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. Eur J Clin Microbiol Infect Dis (2005) 1.09
Lessons from an epidemic, again. N Engl J Med (2001) 1.07
Risk factors for antibiotic-resistant infection and treatment outcomes among hospitalized patients transferred from long-term care facilities: does antimicrobial choice make a difference? Clin Infect Dis (2003) 1.06
Reactive hemophagocytic syndrome: a new presentation of disseminated histoplasmosis in patients with AIDS. Clin Infect Dis (1995) 1.06
Strategies for prevention and control of multiple drug-resistant nosocomial infection. Am J Med (1981) 1.04
Pressure transducers as a source of bacteremia after open heart surgery. Report of an outbreak and guidelines for prevention. Chest (1976) 1.03
Control of aminoglycoside resistance by barrier precautions. Infect Control (1983) 1.01
The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol (1996) 1.01
Caribbean sponge-related Pseudomonas folliculitis. JAMA (1987) 1.01
The case for face masks-zorro or zero? Clin Infect Dis (2000) 1.00
Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer (1981) 1.00
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era. Am J Respir Crit Care Med (2000) 0.99
Pilot trial of selective decontamination for prevention of bacterial infection in an intensive care unit. J Infect Dis (1990) 0.98
The effect of renal dysfunction on antimicrobial use measurements. Clin Infect Dis (2002) 0.98
Factitious meningitis. Diagnostic error due to nonviable bacteria in commercial lumbar puncture trays. JAMA (1975) 0.96
Nosocomial infection caused by antibiotic-resistant organisms in the intensive-care unit. Infect Control Hosp Epidemiol (1996) 0.96
Infection control in intensive care units and prevention of ventilator-associated pneumonia. Semin Respir Infect (2000) 0.96
Delays in tuberculosis isolation and suspicion among persons hospitalized with HIV-related pneumonia. Chest (2000) 0.96
Pseudomonas in the sinks in an intensive care unit: relation to patients. J Clin Pathol (1984) 0.95
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci. Chemotherapy (1997) 0.93
In-vitro resistance to zidovudine and alpha-interferon in HIV-1 isolates from patients: correlations with treatment duration and response. Ann Intern Med (1992) 0.93
"Curbside" consultation and informal communication in medical practice: a medicolegal perspective. Clin Infect Dis (1996) 0.93
Interventional evaluation of environmental contamination by vancomycin-resistant enterococci: failure of personnel, product, or procedure? J Hosp Infect (2008) 0.92
Meningorectal fistula as a cause of polymicrobial anaerobic meningitis. Am J Clin Pathol (1982) 0.91
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Am J Med (1989) 0.91
Eosinophilic meningitis and ibuprofen therapy. Neurology (1984) 0.90
Post-flood measurement of fungal bio-aerosol in a resource-limited hospital: can the settle plate method be used? J Hosp Infect (2013) 0.89
A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis (1995) 0.89
Infections with gram-negative bacilli in a cardiac surgery intensive care unit: the relative role of enterobacter. J Hosp Infect (1988) 0.89
HIV-related Pneumocystis carinii pneumonia in older patients hospitalized in the early HAART era. J Gen Intern Med (2001) 0.89
Interferon-alpha plus zidovudine in HIV infection. Lancet (1989) 0.88
Multi-hospital analysis of antimicrobial usage and resistance trends. Diagn Microbiol Infect Dis (2001) 0.88
Recovery of nosocomial fecal flora from frozen stool specimens and rectal swabs: comparison of preservatives for epidemiological studies. Diagn Microbiol Infect Dis (1997) 0.88
Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction. J Infect Dis (1992) 0.86
Severe, reversible neutropenia during high-dose mebendazole therapy for echinococcosis. JAMA (1983) 0.86
Selective survival in pentazocine and tripelennamine of Pseudomonas aeruginosa serotype O11 from drug addicts. J Infect Dis (1985) 0.86
Human bites: review of the literature and report of case. J Oral Surg (1973) 0.85
The effect of epidermal growth factor on the septic complications of acute pancreatitis. J Surg Res (1997) 0.85
Resistant bacteria and infection control in the nursing home and hospital. Bull N Y Acad Med (1987) 0.84
A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1994) 0.84
Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.84
The effect of glucagon-like peptide 2 on intestinal permeability and bacterial translocation in acute necrotizing pancreatitis. Am J Surg (2001) 0.84
Cancrum oris-like lesion associated with acute myelogenous leukemia. Oral Surg Oral Med Oral Pathol (1974) 0.84
The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. Am Surg (1999) 0.84
Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami: 1987-1990. J Infect Dis (1995) 0.84
Sternal osteomyelitis and mediastinitis after open-heart operation: pathogenesis and prevention. Ann Thorac Surg (1976) 0.83
Infective endocarditis in injection drug users: importance of human immunodeficiency virus serostatus and degree of immunosuppression. Clin Infect Dis (1996) 0.83
Gram-negative bacilli in human milk feedings: quantitation and clinical consequences for premature infants. J Pediatr (1986) 0.82
A guide to interpreting economic studies in infectious diseases. Clin Microbiol Infect (2010) 0.82
The role of the microbiology laboratory in surveillance and control of nosocomial infections. Am J Clin Pathol (1978) 0.82